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We describe a technology for the profiling of miRNA
expression in intact cells. The technology is based
on sensor oligonucleotides that are cleavable,
completely complementary to a target miRNA, and
dual-labeled with a fluorescent dye and a quencher.
Upon entering the cell, the sensor oligonucleotide
binds its specific miRNA target through com-
plementary base-pairing. This triggers assembly of
the endogenous RNA Induced Silencing Complex
(RISC) around the miRNA-sensor duplex and
cleavage of the sensor oligonucleotide, resulting in
separation between the dye and quencher, and a
fluorescence turn-on. In the presented feasibility
studies, we focus on a specific miRNA (miR-10b)
implicated in breast cancer metastasis. Using a
human breast adenocarcinoma cell line, we illustrate
the application of this technology for miRNA detec-
tion with nanomolar sensitivity in both a cell-free
system and intact cells.
INTRODUCTION
The recent literature abounds in examples of the key role played
by miRNAs in determining cell fate. Their fundamental impor-
tance is particularly well defined with regard to cancer emer-
gence, progression, and response to therapy (Gabriely et al.,
2011; Hurst et al., 2009; Iorio and Croce, 2012; Ma et al., 2007;
Nicoloso et al., 2009). Consequently, miRNAs represent prom-
ising candidates as targets of therapeutic intervention, high-
lighting the importance of developing miRNA detection methods
for preclinical/clinical applications.
The currently established methods for microRNA detection
in situ rely on PCR and northern blotting, or high-affinity hybrid-
ization probes (Driskell et al., 2009; Havelda, 2010; Husale et al.,
2009; Li et al., 2009, 2010; Lu and Tsourkas, 2009; Mandir et al.,
2009; Nelson et al., 2004; Nuovo et al., 2009; Po¨hlmann and
Sprinzl, 2010; Silahtaroglu et al., 2007; Song et al., 2010). How-
ever, none of these methods are applicable in intact live cells.Chemistry & Biology 21, 199Consequently, these methods do not permit studies, in which
the ‘‘evolution’’ of the cell’s phenotype is monitored in an intact
cellular environment. In addition, many of the existing methods
rely on direct hybridization of the sensor oligo with the miRNA,
reflecting a 1:1 ratio of fluorescent probe per miRNA and result-
ing in lower sensitivity. Clearly, more sensitive and inexpensive
methods are needed to detect cellular miRNAs. To overcome
these hurdles, we developed a method that employs a powerful
signal amplification strategy. In our approach, each miRNA
molecule mediates catalytic cleavage of its sensor substrate
consisting of an RNA oligo that is fully complementary to the
target miRNA. This results in the cleavage of numerous synthetic
substrates by a single miRNA-RISC complex. The described
technology offers the possibility for miRNA detection using a
simple, inexpensive ($40/l of assay solution) and rapid (2 hr
for 96 samples) assay format.
The specificmechanism behind our technology is described in
Figure 1. The sensor oligonucleotides are composed of RNA
bases, are cleavable (nonstabilized by chemical modification)
around the seed region (the conserved region within which the
microRNA engages the RNA substrate), and are labeled with a
fluorescent dye-quencher pair, so that upon cleavage of the
oligonucleotide by the microRNA-RISC fluorescence enhance-
ment is observed (Figure 1A). Upon internalization of the sensor
oligos by the cell, the sensors efficiently engage the endogenous
cytosolic RNA interference apparatus in a sequence-specific
way. We designed the sensor oligos to be fully complementary
to endogenous miRNA species and, as such, to base pair with
their miRNA targets (Figure 1BI). This binding event leads to
the recruitment to the duplex of the endogenous RNA induced
silencing complex (RISC) (Figure 1BII) and cleavage of the oligo
at a specific position in the seed region (Figure 1BIII). This
cleavage results in separation between the quencher and the
dye located at the ends of the sensor oligo, and fluorescence
turn-on. The microRNA is released from the complex and is
free to catalyze subsequent cleavage reactions (Figure 1BIII).
Here, we demonstrate the feasibility of the approach by
focusing on one miRNA (miR-10b) implicated in breast cancer
metastasis (Yigit et al., 2013; Baffa et al., 2009; Ma et al., 2007,
2010). However, this methodology can be applied for the detec-
tion and profiling of miRNA expression in a wide variety of
preclinical and clinical scenarios.–204, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 199
Figure 1. Sensor Design and Mechanism of Action
(A) The sensor oligonucleotides are composed of RNA bases, are cleavable
(nonstabilized by chemical modification) around the seed region, and are
labeled with a fluorescent dye-quencher pair, so that, upon cleavage of
the oligonucleotide by the miRNA-RISC, fluorescence enhancement is
observed.
(B) Upon internalization of the sensor oligos by the cell, the sensors base pair
with their miRNA targets (I). This binding event leads to the recruitment to the
duplex of the endogenous RNA induced silencing complex (RISC) and
cleavage of the oligo at a specific position in the seed region (II). This cleavage
results in separation between the quencher and dye located at the ends of the
sensor oligo, and fluorescence turn-on. The miRNA is released from the
complex and is free to catalyze subsequent cleavage reactions (III).
Chemistry & Biology
Detection of miRNA Expression in Intact CellsRESULTS
To assess the feasibility of the approach, we performed a study
in which we designed a cleavable sensor oligo to detect miR-10b
expression. miR-10b has been implicated in epithelial to mesen-
chymal transition and breast cancer metastasis by multiple
studies including by our own group (Yigit et al., 2013; Baffa
et al., 2009; Ma et al., 2007, 2010). Specifically, we designed
an RNA sensor oligonucleotide that was completely comple-
mentary to the miRNA-10b seed region and was conjugated to
a Cy5 dye at the 50 end and Iowa Black RQ quencher at the 30
end. Its sequence was AC AAA UUC GGU UCU ACA GGG UA.
First, we determined the signal-to-background ratio of the
sensor by incubating the oligo with RNase and recording fluores-
cence intensity against a noncleaved oligonucleotide control. As
seen in Figure 2, cleavage of the oligo resulted in a 566%fluores-
cence enhancement over the noncleaved sensor oligo incubated
in RNase-free conditions.
To determine the sensitivity of detection with the minimum
number of variables, we designed a cell-free assay, based on re-
ports in the literature (Brown et al., 2005; Robb et al., 2005).
Studies were performed using cytoplasmic extracts from the
metastatic human breast cancer cell line MDA-MB-231-luc-
D3H2LN. In cytoplasmic extracts treated with anti-miR-10b
locked nucleic acid (LNA) antisense oligonucleotides to miR-200 Chemistry & Biology 21, 199–204, February 20, 2014 ª2014 Else10b (ASO) (termed miR-10b-depleted control), miRNA-10b was
inhibited. Consequentially, when the miR-10b sensor oligo was
titrated into these ASO-treated extracts, we did not observe a
significant increase in fluorescence (Figure 3A, bottom row). In
contrast, in the extracts incubated with irrelevant scrambled
oligo (SCR ASO), which does not inhibit miR-10b or any other
of the annotated miRNAs, we observed distinctive fluorescence
enhancement with increased concentration of the sensor oligo
(Figure 3A, upper row). Using linear regression analysis (Fig-
ure 3B) and the formula detection limit = 3(sigma)/slope, we
calculated a detection limit of 13.4 nM. The observed fluores-
cence enhancement was indeed due to sensor cleavage.
Samples from the cell-free assay were resolved by gel electro-
phoresis (Figure 3C). These experiments showed the presence
of intact sensor (positive staining with ethidium bromide) in the
samples where miR-10b was inhibited by treatment with miR-
10b ASO but not in the samples treated with SCR ASO in which
miRNA-10b remained active and cleaved the sensor.
To test the hypothesis that the sensor is capable of reporting
on miRNA expression in intact cells, we incubated MDA-MB-
231-luc-D3H2LN cells with miR-10b-specific sensor oligo.
miR-10b-depleted cells obtained by inhibiting miR-10b with
ASO served as control. As shown in Figures 4A and 4B, there
was a significant difference in signal between miR-10b-active
andmiR-10b-depleted control cells (p < 0.05). These differences
were independent of sensor concentration above 250 nM. Back-
ground fluorescence was negligible (Figure S1 available online).
Fluorescence appeared only after sensor cleavage and
continued to increase over a period of time (Figure S1). To esti-
mate the rate of sensor ‘‘turn-on,’’ we performed a time-course
study at a fixed sensor concentration of 125 nM. Maximum fluo-
rescence intensity was reached within 16 hr (Figure 4C). In con-
trol cells depleted of miR-10b, the rate of sensor cleavage (non
specific) was low, and, even after 48 hr of incubation, the fluores-
cence intensity did not reach maximum. A similar trend was
observed with 4T1 breast adenocarcinoma cells (Figure S2).
To test if incubation with the sensor affects cell viability, we
assessed levels of apoptosis at the end of 48 hr of incubation.
No difference was observed between treated and control cells
(Table S1).
Fluorescencemicroscopy using a 250 nM concentration of the
sensor revealed that cells could be easily delineated based on
fluorescence from the sensor, which is an important element in
a potential histopathological setting aimed at identifying cells
with high metastatic potential (Figure 4D).
Finally, as an illustration of a related application, flow cyto-
metry was used to compare miR-10b active or miR-10b-
depleted cells (Figure 4E). This experiment confirmed our
observations using epifluorescence that the proposed approach
could quantitatively reflect differences in miRNA expression.
Irrespective of the method used (flow cytometry or epifluores-
cence), the miRNA expression as measured by our approach
was accurate, because it fell within one SD of the measurement
obtained by the gold-standard real-time qRT-PCR (Figure 4F).
DISCUSSION
We have developed sensor oligonucleotide that can report on
miRNA expression in intact cells. Another unique feature of thevier Ltd All rights reserved
Figure 2. Signal-to-Background Ratio for
the miR-10b Sensor
Cleavage of the oligo by RNase resulted in a 566%
fluorescence enhancement over the noncleaved
oligo incubated in RNase-free buffer.
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targets can be analyzed in a low-cost high-throughput format.
This capability holds potential in both preclinical and clinical
settings. For example, as a research tool, it can be instrumental
in elucidating the role played by miRNAs in regulating cell fate.
Clinically, one can envision a scenario in which, as part of routine
histopathology, biopsied tissues are examined by the proposed
method to highlight individual cells with aberrant miRNA profiles
that could signify high metastatic potential, precancerous
lesions that are likely to progress, etc. Another potential scenario
can take advantage of the capacity to isolate and analyze
circulating tumor cells, as surrogates for a primary malignancy.
Finally, a modified assay can be designed to permit analysis of
noncellular body fluids, provided that key components of the
RNAi apparatus are exogenously supplied.
With these practical implications in mind, several issues need
to be discussed. First, a question that can be raised has to do
with the potential of the sensors to detect all miRNAs, because,
in mammals, a large number of miRNAs do not primarily regulateChemistry & Biology 21, 199–204, February 20, 2014gene expression by degradation of target
mRNAs but rather by translational repres-
sion. However, recent research suggests
that the prevalence of miRNA-dependent
degradation targets in mammals is higher
than previously thought and that the
choice between mRNA degradation and
translational repression is dependent on
the degree of complementarity between
the mRNA target and the miRNA seed re-
gion (Bracken et al., 2011). This hypothe-
sis is also supported by our preliminary
results, in which the miR-10b-specificsensor oligonucleotide is cleaved by miR-10b, despite the fact
that all of miR-10b’s known mRNA targets are regulated by
translational repression and not mRNA cleavage.
A second issue has to do with the possibility to optimize the
design of the sensors to minimize background fluorescence
and increase sensitivity. It is conceivable that the detection limit
can be enhanced by decreasing the length of the oligonucleotide
(less than 22 nucleic acids) and by modifying the combination of
fluorescent dye and quencher. In the current feasibility studies,
the oligo was terminally labeled with the dye and quencher.
Consequently, the two were separated by 22 nucleotides
(7.5 nm). Alternatively, one could internally label the oligo and
have a 10 nucleotide (nt) distance (3.4 nm) between the dye
and the quencher, which will result in an >95% quenching effi-
ciency and reduced background. Specifically, sensors can be
synthesized using 20 nt oligos, labeled with a quencher-dye
pair spanning the 8 nt seed region. This is well within the limit
of 5–10 nm (15–30 nucleotides) imposed by the physics of fluo-
rescence resonance energy transfer. The specific quenchingFigure 3. miR-10b Detection in a Cell-free
System
(A) Epifluorescence imaging. Two different scales
are shown for sensor oligo concentrations above
and below 10 nM, to avoid signal saturation at the
higher concentrations when optimal resolution is
achieved at the lower concentrations.
(B) Quantification of radiant efficiency from (A). The
results indicated a detection limit of 13.4 nM. Error
bars represent SD.
(C) Gel electrophoresis followed by ethidium
bromide staining confirmed cleavage of the sensor
oligo (i.e., there is no detectable band corre-
sponding to intact sensor oligo in the treatment
group). In the control group, in which miR-10b is
inhibited by antisense oligonucleotides, there is no
cleavage of the sensor oligo, and the band is
preserved.
ª2014 Elsevier Ltd All rights reserved 201
Figure 4. miR-10b Detection in Intact Cells
(A) Radiant efficiency as a function of sensor concentration from epifluorescence optical imaging. Error bars represent SD.
(B) Time course of sensor activation. Representative images at 3, 16, 24, and 48 hr of incubation.
(C) Quantitative analysis of images shown in (B). Error bars represent SD.
(D) Fluorescence microscopy of intact cells.
(E) Flow cytometry of intact cells.
(F) Quantitative analysis of epifluorescence imaging, flow cytometry, and the gold-standard real-time qRT-PCR at a sensor concentration of 250 nM. Error bars
represent SD.
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99% at a distance of 3 nm (ten bases) (http://biosupport.licor.
com/docs/QC-1DarkQuencher_v5.pdf). In addition, at this dis-
tance, steric hindrance would not present an issue. As an
example, the cited quencher-dye combinations are used
commercially as sensors for caspase activity using cleavage of
the 2.9 nm GDEVDGAK octapeptide substrate (LI-COR Biosci-
ences; http://biosupport.licor.com/docs/
QC-1DarkQuencher_v5.pdf). In our scenario, a 10 nt distance
between the quencher and dye would have a length of 3.4 nm
(10 3 3.4 A˚/nucleotide = 34 A˚ = 3.4 nm). For the IRDye 700DX-
QC-1 pair, the expected quenching efficiency at that distance
will be 98.8%. In addition, the overall fluorescence turn-on
upon dequenching is expected to exceed that reported for 1:1
hybridization probes, because our method takes advantage of
a specific signal amplification strategy. Namely, a single miRNA
will trigger the cleavage of numerous substrate oligos, because
RNAi is a ‘‘catalytic’’ molecular mechanism. Unlike hybridization
probes (e.g., molecular beacons and SmartFlare, Millipore) our
sensor does not remain bound to and ‘‘hijack’’ the target. Conse-
quently, our sensor is not expected to interfere with cellular
function.202 Chemistry & Biology 21, 199–204, February 20, 2014 ª2014 ElseAll of these optimization steps are warranted but outside the
purview of this early work, which has as its key goal to establish
the feasibility of profiling miRNA signatures in intact cells. This is
important because it is only through such studies that one can
capture the true dynamics of miRNA regulation of cell fate.
Because the method is rapid and noninvasive, it allows for
collection of time-course data in genuine cellular environments
and thus gaining a better understanding of individual-to-
individual variation, authentic molecular processes, and long-
term trends.
SIGNIFICANCE
We describe a method for detecting miRNA signatures in
intact cells. This mechanism of miRNA detection can be
applicable to a variety of endogenous target miRNAs as
useful biomarkers for diagnosis and prognosis
in preclinical/clinical settings. The key advantage of the
technology is the capacity for analysis in intact cells.
This is important because it is only through such studies
that one can capture the true dynamics of miRNA
regulation of cell fate. Other unique features of thevier Ltd All rights reserved
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The sensor oligonucleotide (50-Cy5/rCrArCrArArArUrUrCrGrGrUrU rCrUrArCr
ArGrGrGrUrA/IAbRQSp-30) was purchased from Integrated DNA Technolo-
gies. The oligo was composed of RNA bases. The 50 and 30 ends of the
sequence were modified with Cy5 (fluorescent dye) and Iowa Black RQ
(quencher), respectively. miRNA-10b miRCURY LNA microRNA Inhibitors
(termed ASO) were purchased from Exiqon.
Experiments to Determine the Signal-to-Background Ratio of the
Sensor Oligonucleotides
We determined the signal-to-background ratio of the sensor by incubating
100 nM of the oligo with a 10 mg/ml of RNase and recording fluorescence
intensity (IVIS Spectrum epifluorescence optical imaging system, Caliper;
649 nm excitation; 670 nm emission) against a noncleaved oligonucleotide
control (sensor oligonucleotides incubated in RNase-free water).
Cells
The metastatic human breast cancer cell line MDA-MB-231-luc-D3H2LN was
purchased from Caliper Life Sciences and cultured in Dulbecco’s modified
Eagle’s medium (Sigma) supplemented with 10% fetal bovine serum (FBS)
(Thermo Scientific), 1% antibiotics (Invitrogen), and 2 mM L-glutamine, per
the supplier’s instructions. Mouse epithelial mammary gland tumor cell line
4T1 was purchased from ATCC and maintained in RPMI supplemented with
10% FBS and 1% antibiotics as per ATCC guidelines.
Preparation of Cell Extracts
The protocol was modified from Brown et al. (2005) and Robb et al. (2005).
MDA-MB-231-luc-D3H2LN cells were washed three times with ice-cold PBS
(pH 7.2) and lysed for 10 min on ice by gentle mixing in four packed cell
volumes of cell lysis buffer (20 mM HEPES [pH 7.9], 10 mM NaCl, 1 mM
MgCl2, 0.5M sucrose, 0.2mMEDTA, 0.5mMDTT, 0.5mMphenylmethanesul-
fonylfluoride [PMSF], 0.35% (v/v) Triton X-100). The nuclear fraction was
removed by centrifugation at 760 3 g for 10 min at 4C. The supernatant
was transferred to new Eppendorf tubes and cold buffer B (0.11 volumes;
20 mM HEPES [pH 7.9], 10 mM NaCl, 1 mM MgCl2, 0.35 M sucrose, 0.2 mM
EDTA, 0.5 mM DTT, 0.5 mM PMSF) was added. Cytoplasmic extracts were
quickly stored in aliquots at80C. Protein concentration (8mg/ml) was deter-
mined using Bradford protein assay (Bio-Rad).
miRNA-Mediated Sensor Cleavage: Cell-free Assay
Sensor oligonucleotide (3.125, 6.25, 12.5, 25, 50, 100 nM) was incubated
with untreated cell extracts or cell extracts pretreated with anti-miR10b
locked nucleic acid (LNA) antisense oligonucleotides (ASO, Exiqon at a
10-fold excess of ASO to sensor). The extracts were incubated at 37C for
2 hr in the following buffer: 40% (v/v) cell extracts (80 mg), 1 mM ATP,
0.2 mM GTP, 1 U/ml RNasin (Promega), 30 mg/ml creatine kinase, 25 mM
creatine phosphate (Sigma), 2 mM MgCl2, and 20 mM NaCl and buffer D
(100 mM KCl, 20 mM HEPES [pH 7.9], 2% [v/v] glycerol, and 0.2 mM
EDTA) in a final reaction volume of 25 ml. The cleavage reactions were
stopped by adding eight volumes (200 ml) of proteinase K buffer (200 mM
Tris-HCl [pH 7.5], 25 mM EDTA, 300 mM NaCl, 2% [w/v] SDS and
0.6 mg/ml proteinase K [Invitrogen]). Reactions were incubated at 37C for
15 min. Fluorescence was recorded using IVIS spectrum optical imaging
system (Cy5 channel; 649 nm excitation, 670 nm emission, cutoff: 665,
PerkinElmer). For sensor cleavage analysis, samples were resolved on a
gel and stained with ethidium bromide.
Transfection and miRNA-Mediated Sensor Cleavage: Intact Cell
Assay
For transfection, MDA-MB-231-luc-D3H2LN cells were plated in a black
96-well plate at a seeding density of 30,000 cells per well in 0.2 ml of growth
medium consisting of DMEM with 10% FBS. Cells were grown at 37C forChemistry & Biology 21, 19924 hr, the medium was removed, and 100 ml of serum free media (no
antibiotics) was added. Cells were then transfected with an excess of
miRNA-10b ASO or SCR ASO (5 mM) using Lipofectamine RNAiMAX (Invi-
trogen), according to the manufacturer’s instructions. Following, varying con-
centrations of miRNA-10b sensor oligonucleotide (0, 25, 50, 100, 250, 500,
750, 1,000 nM) were added to all wells, and the plate was incubated for addi-
tional 3 hr. The transfection media containing sensor oligonucleotide was
removed, complete media were added to the cells, and the cells were incu-
bated for 24 hr. Fluorescence was recorded in the Cy5 channel using IVIS
spectrum optical imaging system (649 nm excitation; 670 nm emission). For
time-course study, fluorescence from the same plate was recorded at the
specified time points up to 48 hr.
SUPPLEMENTAL INFORMATION
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